SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Space Exploration Technologies Corp. engages in the design, manufacture, and launch of rockets and spacecrafts. It provides satellite communication services. The company was founded by Elon Reeve Musk on March 14, 2002 and is headquartered in Hawthorne, CA.

Space Exploration Technologies Corp. - Ordinary Shares - Class A

SpaceX

Investors are actively debating the long-term viability of the SpaceX IPO, with bulls highlighting the company's ambitious infrastructure goals and potential for future index inclusion, while bears warn of extreme overvaluation and persistent cash burn. Community discourse remains polarized between those viewing this as a generational buy and others cautioning against significant downside risk as the initial hype meets real-world fundamentals.

Paramount Skydance Corp. is a next-generation global media and entertainment company that engages in providing content creation and distribution services. It operates through the following business segments: Studios, Direct-to-Consumer, and TV Media. Its portfolio unites brands including Paramount Pictures, Paramount Television, CBS, CBS News, Nickelodeon, MTV, BET, Comedy Central, Showtime, Paramount Plus, Pluto TV, and Skydance’s Animation, Film, Television, Interactive/Games, and Sports divisions. The company is headquartered in New York, NY.

Paramount Skydance Corp. - Ordinary Shares - Class B

Paramount Skydance is trending as the community closely monitors the progress of its $110 billion acquisition of Warner Bros. Discovery following the Department of Justice's approval. Shareholders are actively debating the potential for long-term synergy value, the impact of ongoing regulatory reviews in Europe, and the strategic implications of management's integration plans while remaining focused on upcoming deal closing milestones.

AST Spacemobile, Inc. engages in building a broadband cellular network in space to operate directly with standard, unmodified mobile devices based on an extensive IP and patent portfolio. It focuses on providing mobile broadband services with global coverage to all end-users, without the need to purchase special equipment. The company was founded by Abel Avellan on May 31, 2017 and is headquartered in Midland, TX.

AST SpaceMobile Inc - Ordinary Shares - Class A

AST SpaceMobile Inc

AST SpaceMobile is facing significant downward pressure and high volatility as investors rotate capital out of existing sector names to gain exposure to the high-profile SpaceX public listing. While some market participants express concern over valuation and execution timelines, many in the community view this pullback as a temporary liquidity event and are actively looking to accumulate positions ahead of upcoming satellite launch catalysts.

Entrepreneurshares Series Trust - ERShares Private-Public Crossover ETF

Investors are expressing frustration over the ETF's lack of upward momentum despite its concentrated holding in SpaceX, with many in the community debating the impact of the fund's SPV-based valuation structure versus direct equity exposure. Discussions focus on whether the market is discounting the fund's private asset holdings ahead of a broader public launch or if the current price action reflects concerns regarding transparency and the fund's long-term growth potential.

Destiny Tech100, Inc. operates as a non-diversified, closed-end management investment company. The company was founded on November 18, 2020 and is headquartered in Austin, TX.

Destiny Tech100 Inc

DESTINY TECH 100 INC

Investors are actively debating whether Destiny Tech 100 remains a viable proxy for SpaceX exposure or a value trap following the recent share offering and the impending public debut of the underlying holding. While some community members view the current volatility as a discount opportunity before subsequent Anthropic and OpenAI IPOs, others remain skeptical, citing concerns over management's dilution strategy and a potential decline in the fund's scarcity premium.

Roku, Inc. engages in the provision of a streaming platform for television. It operates through the following segments: Platform and Devices. The Platform segment includes the sale of digital advertising and distribution of streaming services. The Devices segment is involved in the sale of streaming players, Roku-made televisions, smart home products and services, audio products, and related accessories. The company was founded by Anthony J. Wood in October 2002 and is headquartered in San Jose, CA.

Roku Inc - Ordinary Shares - Class A

Roku Inc

Roku shares are experiencing significant volatility and trading volume following reports that the streaming platform is engaged in early-stage buyout discussions with a major media company. While investors are debating the credibility of these rumors and the potential valuation, the community is actively discussing the company's long-term potential in the ad-supported streaming market and the implications of a possible consolidation deal.

Omeros Corp. operates as a biopharmaceutical company, which engages in the research, discovery, development, and commercialization of small-molecule and protein therapeutics targeting immunologic diseases. It also offers orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system. The company was founded by Gregory A. Demopulos and Pamela Pierce Palmer on June 16, 1994 and is headquartered in Seattle, WA.

Omeros Corporation

Omeros Corp

Omeros Corp is trending as investors await the first full commercial revenue report for YARTEMLEA, with the community actively debating whether the company can meet high expectations following its recent FDA approval and partnership deals. Discussion is dominated by speculation over whether recent price volatility is driven by institutional shakeouts ahead of upcoming EMA regulatory decisions or by ongoing short interest as the company shifts into a commercial-stage growth phase.

Amkor Technology, Inc. engages in the provision of outsourced semiconductor packaging and test services. Its services include design, package characterization, test, and wafer bumping services. The company was founded in 1968 and is headquartered in Tempe, AZ.

AMKOR Technology Inc.

Amkor Technology is trending as the stock surges following a major announcement that it is breaking ground on an expanded multi-billion dollar semiconductor packaging campus in Arizona. The community is actively discussing this expansion as a key play on domestic semiconductor onshoring and the growing necessity of advanced packaging to support the AI supply chain.

ProShares Trust II - ProShares Ultra Bloomberg Natural Gas 2x Shares

ProShares Ultra Bloomberg Natural Gas

BOIL is trending as investors react to volatility in the natural gas market, with community discussions largely centered on the implications of the upcoming 1-for-2 reverse stock split and seasonal inventory storage projections. Traders are debating whether the current price levels represent a bottom or if ongoing contango decay will continue to pressure the fund, leading many to closely watch technical support levels and weather-driven demand catalysts.

Albemarle Corp. engages in the development, manufacture, and marketing of chemicals for consumer electronics, petroleum refining, utilities, packaging, construction, transportation, pharmaceuticals, crop production, food-safety, and custom chemistry services. It operates through the following segments: Energy Storage, Specialties, and Ketjen. The Energy Storage segment develops and manufactures a broad range of basic lithium compounds, including lithium carbonate, lithium hydroxide, and lithium chloride. The Specialties segment focuses on optimizing a portfolio of bromine and specialized lithium solutions. The Ketjen segment consists of clean fuels technologies, fluidized catalytic cracking catalysts and additives, and performance catalyst solutions, which is primarily composed of organometallics and curatives. The company was founded in 1993 and is headquartered in Charlotte, NC.

Albemarle Corp.

Albemarle Corp

Albemarle Corporation is trending as investors respond to stabilizing lithium prices, rebounding energy storage demand, and improved earnings outlooks that have spurred a series of analyst upgrades. The community is actively discussing the stock's recent bullish breakout, with many investors debating whether to lock in profits from the significant recovery or hold for further gains amid a perceived shift in the lithium market cycle.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Why Is Agenus (AGEN) Down 9.6% Since Last Earnings Report?

Agenus (AGEN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

AGEN Early Access Revenues Signal a New Path Ahead of Approval

Agenus turns early physician demand for BOT+BAL into revenues and real-world data, testing its launch strategy before formal approval.

Is Agenus Stock a Hold Amid Valuation and Funding Risks?

AGEN trades below peers on sales multiples, but BOT+BAL's promise is offset by funding needs, dilution risk and a going-concern warning.

AGEN BOT+BAL: What the BATTMAN Trial Means for mCRC

Agenus bets on BOT+BAL in MSS mCRC, and the phase III BATTMAN trial determines whether early survival signals translate into a pivotal win.

Agenus Announces Virtual 2026 Annual Shareholders Meeting

Agenus Inc. (Agenus) (NASDAQ: AGEN), a leader in immuno-oncology innovation, today announced that its Annual Shareholders Meeting will begin at 10:00 a.m. ET on June 16, 2026, and will be conducted in a virtual format only. Registration for attendees will start at 9:45 a.m. ET. To participate in...

IBRX Stock Outlook After Q1 Results and a New FDA Review

ImmunityBio eyes a steadier path after a 290% YTD surge as investors watch Anktiva demand, FDA review timing and execution risks.

ImmunityBio: Anktiva Explained and What Comes Next

IBRX's Anktiva drives a 668% revenues jump in 2025 as ImmunityBio expands bladder cancer approvals and pursues new catalysts.

AGEN vs. IOVA: Which Cancer Biotech Stock Has More Upside Potential?

Iovance's commercial momentum and expanding Amtagvi pipeline make it appear better positioned than Agenus despite higher valuation.

How Agenus' Pipeline Progress Unlock Its Next Growth Phase

AGEN advances BOT/BAL into phase III for MSS colorectal cancer as survival data and global access efforts shape its next growth phase.

Agenus Presents Phase 2 BOT+BAL Melanoma Data Showing Durable Responses and Meaningful Survival in Advanced Checkpoint-Refractory Melanoma at ASCO 2026

Agenus Inc. (Nasdaq: AGEN), a leader in immuno-oncology innovation, today announced the first disclosure of Phase 2 data from the C-800-23 study evaluating botensilimab (BOT), Agenus multifunctional Fc-enhanced anti-CTLA-4 antibody, with balstilimab (BAL), an anti-PD-1 antibody, in patients with...

This account has been verified as an official AGEN representative.

Verified Account

Agenus Communications

Agenus, Inc. is a clinical-stage company, which engages in the development and commercialization of technologies to treat cancers and infectious diseases. Its product pipeline includes Balstilimab, Zalifrelimab, AGEN1181, AGEN1327, AGEN2373, AGENt-797 and AGEN1777. The company was founded by Garo H. Armen and Pramod K. Srivastava on March 31, 1994 and is headquartered in Lexington, MA.

AGENAgenus Inc

Fundamentals

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest AGEN News